6. How It Works
Four stages take a biological sample from collection to a verifiable, tradable token.
1. Biological Asset Creation
Cord blood samples are collected and processed at FDA-compliant facilities. Automated platforms generate a Proof of Process (PoP) and a Proof of Quality (PoQ) for each unit.
2. Secure Biological Storage
Samples are placed in automated cryogenic vault systems featuring robotic storage, real-time tracking, tamper-proof inventory, and full lifecycle monitoring.
3. Private Blockchain Registry
Each biological asset is recorded on a private blockchain, ensuring data integrity, anonymized records, cryptographic verification, and HIPAA-compliant privacy.
4. Tokenization
Each CBU is tokenized into two layers, BRIC (biological cell units) and BRICO (blockchain tokens), according to its grade, BLA or non-BLA. This makes the underlying asset standardized, verifiable, and liquid.
Lifecycle
Figure 6.1 in the source whitepaper summarizes the lifecycle:
- Collection: CBU collected at FDA-compliant facilities.
- Processing: automated purification through AXP® II / PXP-1000®.
- Storage: robotic cryogenic vault through BioArchive®.
- Registry: private blockchain record with PoP and PoQ.
- Tokenization: issued as BRIC and BRICO.
Asset Backing
Just as gold once backed the global financial system, verified biological assets can back a new generation of digital finance. Real samples, verified laboratory data, automated storage records, and cryptographic audit trails together create a new category of RWA: Biological Assets.